B. Metzler Seel. Sohn & Co. Ag Dexcom Inc Transaction History
B. Metzler Seel. Sohn & Co. Ag
- $10 Billion
- Q3 2024
A detailed history of B. Metzler Seel. Sohn & Co. Ag transactions in Dexcom Inc stock. As of the latest transaction made, B. Metzler Seel. Sohn & Co. Ag holds 22,578 shares of DXCM stock, worth $2 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
22,578
Previous 56,758
60.22%
Holding current value
$2 Million
Previous $6.44 Million
76.49%
% of portfolio
0.02%
Previous 0.07%
Shares
12 transactions
Others Institutions Holding DXCM
# of Institutions
1,021Shares Held
352MCall Options Held
5.51MPut Options Held
5.6M-
Vanguard Group Inc Valley Forge, PA47.4MShares$4.21 Billion0.06% of portfolio
-
Black Rock Inc. New York, NY34.5MShares$3.06 Billion0.09% of portfolio
-
Capital Research Global Investors Los Angeles, CA17.9MShares$1.59 Billion0.26% of portfolio
-
State Street Corp Boston, MA16.7MShares$1.48 Billion0.05% of portfolio
-
Baillie Gifford & CO15MShares$1.33 Billion0.77% of portfolio
About DEXCOM INC
- Ticker DXCM
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 386,257,984
- Market Cap $34.3B
- Description
- DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...